Smith Group Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Smith Group Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell
2015 Q4	$789K	Buy
2014 Q1	–	Sell
2013 Q4	$2.22M	Sell
2013 Q3	$2.14M	Sell
2013 Q2	$468K	Buy